ARCHIVES

In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

Organ Systems Program Finally Loses a Couple, But Gets OK for Breast Cancer Risk Study RFA

June 20, 1986

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

December 17, 2013

NIH Faces Cuts Under House, Senate, Administration Plans

May 19, 1995

New Breast Cancer Trials to Include Pre Vs. Post Operative Chemotherapy, CSF Pilot Studies

August 5, 1988

Survey supports removal of cancer care cuts from Medicare bills.

September 26, 2003